Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights
Mohamed A. Abdelgawad, Arafa Musa, Atiah H. Almalki, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 2325-2337
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints
Mithun Rudrapal, Kevser Kübra Kırboğa, Mohnad Abdalla, et al.
Molecular Diversity (2024) Vol. 28, Iss. 4, pp. 2099-2118
Closed Access | Times Cited: 19
New Insights Into the Anticancer Effects of p-Coumaric Acid: Focus on Colorectal Cancer
Wafâa Tehami, Abdelhafid Nani, Naim Akhtar Khan, et al.
Dose-Response (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Hybrid molecules based on caffeic acid as potential therapeutics: A focused review
Xue Zhi Zhao, Ziwei Liu, Hao Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114745-114745
Closed Access | Times Cited: 27
Optimization of pyrazole/1,2,4-triazole as dual EGFR/COX-2 inhibitors: Design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis
Nesma M. Kahk, Fatma El Zahraa Ammar Mohamed, Marwa M. Abdelhakeem, et al.
European Journal of Medicinal Chemistry (2025), pp. 117340-117340
Closed Access
Design, Synthesis, Docking Studies, and Investigation of Dual EGFR/VEGFR‐2 Inhibitory Potentials of New Pyrazole and Pyrazolopyridine Derivatives
Shimaa M. Alhamaky, Nadia A. Khalil, Amr K.A. Bass, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Multitargeting Compounds in Cancer Research
Simone Giovannuzzi, Alessio Nocentini
Interdisciplinary cancer research (2025)
Closed Access
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
Noor ul Amin Mohsin, Sana Aslam, Matloob Ahmad, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1471-1471
Open Access | Times Cited: 26
Optimization of pyrazolo[1,5-a]pyrimidine based compounds with pyridine scaffold: Synthesis, biological evaluation and molecular modeling study
Mohamed A. Abdelgawad, Nadia A. A. Elkanzi, Arafa Musa, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 8, pp. 104015-104015
Open Access | Times Cited: 20
The Benzoxazole Heterocycle: A Comprehensive Review of the Most Recent Medicinal Chemistry Developments of Antiproliferative, Brain-Penetrant, and Anti-inflammatory Agents
Simona Di Martino, Maria De Rosa
Topics in Current Chemistry (2024) Vol. 382, Iss. 4
Closed Access | Times Cited: 3
Green Design, Synthesis, and Molecular Docking Study of Novel Quinoxaline Derivatives with Insecticidal Potential against Aphis craccivora
Mariam Azzam Alanazi, Wael A. A. Arafa, Ibrahim O. Althobaiti, et al.
ACS Omega (2022) Vol. 7, Iss. 31, pp. 27674-27689
Open Access | Times Cited: 14
Modulating Effects of Zingiberaceae Phenolic Compounds on Neurotrophic Factors and Their Potential as Neuroprotectants in Brain Disorders and Age-Associated Neurodegenerative Disorders: A Review
Azraul Mumtazah Razak, Jen Kit Tan, Mazlina Mohd Said, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2564-2564
Open Access | Times Cited: 8
Small-molecule drugs of colorectal cancer: Current status and future directions
Yiren Yang, Pengyu Liu, Mingyang Zhou, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 1, pp. 166880-166880
Closed Access | Times Cited: 8
Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
Chao Wang, Yujing Zhang, Tingting Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127440-127440
Closed Access | Times Cited: 8
Antioxidant and Antimicrobial Potential of 1,8‐Naphthyridine Based Scaffolds: Design, Synthesis and in Silico Simulation Studies within Topoisomerase II
Nadia A. A. Elkanzi, Hajer Hrichi, Alaa Muqbil Alsirhani, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 2
Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)
Mohammad Mahboubi‐Rabbani, Amir Hossein Abdolghaffari, Mahsa Ghesmati, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 733-757
Closed Access | Times Cited: 2
EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones
Arafa Musa, Ehab M. Mostafa, Syed Nasir Abbas Bukhari, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 13
Design and construction of novel pyridine-pyrimidine hybrids as selective COX-2 suppressors: anti-inflammatory potential, ulcerogenic profile, molecular modeling and ADME/Tox studies
Mohamed E. Shaker, Hesham A. M. Goma, Izzeddin Alsalahat, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-14
Open Access | Times Cited: 7
Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation
Mohammed M. Ghoneim, Mohamed A. Abdelgawad, Nadia A. A. Elkanzi, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
IN-SILICO EXPLORATION: UNRAVELING THE ANTI-CANCER POTENTIAL OF 8-NITROQUINOLINE HYDRAZIDES
Sentamil Selvi Ramasamy, Kaviyarasu Adhigaman, Vandana Nandakumar, et al.
Journal of Molecular Structure (2024), pp. 140218-140218
Closed Access | Times Cited: 1
Integration of pharmacophore-based virtual screening, molecular docking, ADMET analysis, and MD simulation for targeting EGFR: A comprehensive drug discovery study using commercial databases
Abdullah R. Alanzi, Ashaimaa Y. Moussa, Mohammed S. Alsalhi, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0311527-e0311527
Open Access | Times Cited: 1
Design, Synthesis, Docking Study of Pyrazolohydrazinopyrimidin‐4‐one Derivatives and Their Application as Antimicrobials
Ruba A. Alolayan, Nadia A. A. Elkanzi, Hajer Hrichi, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 4
Mexican Native Black Bean Anthocyanin-Rich Extracts Modulate Biological Markers Associated with Inflammation
Jonhatan Contreras, Montserrat Alcázar-Valle, Eugenia Lugo‐Cervantes, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 874-874
Open Access | Times Cited: 4
Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action
Afshin Zarghi, Mohammad Mahboubi‐Rabbani, Maryam Abbasi
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 1, pp. 15-36
Closed Access | Times Cited: 7
Identification of Dual-Target Inhibitors for Epidermal Growth Factor Receptor and AKT: Virtual Screening Based on Structure and Molecular Dynamics Study
Hanyu Yang, Zhiwei Zhang, Qian Liu, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7607-7607
Open Access | Times Cited: 3
Thiochromene candidates: design, synthesis, antimicrobial potential and in silico docking study
Rania B. Bakr, Islam H. El Azab, Nadia A. A. Elkanzi
Journal of the Iranian Chemical Society (2021) Vol. 19, Iss. 4, pp. 1413-1423
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top